𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Circulating antibodies to p40AIS in the sera of respiratory tract cancer patients

✍ Scribed by K. Yamaguchi; M. Patturajan; B. Trink; H. Usadel; W. Koch; J. Jen; D. Sidransky


Publisher
John Wiley and Sons
Year
2000
Tongue
French
Weight
81 KB
Volume
89
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Studies of immune recognition in cancer have defined several tumor antigens using autologous cytotoxic T lymphocytes and by detection of serum antibodies to tumor-associated products such as p53 and HER-2/neu. The AIS gene is a p53 homologue with multiple protein products (p40, p51, p63, p73L) on chromosomal arm 3q, frequently amplified and over-expressed in squamous-cell carcinoma of the respiratory tract. We analyzed the humoral response to p40 AIS (a core domain of AIS products without the transactivation domain) by Western blot and ELISA using bacterially synthesized p40 AIS protein. Antibodies were detected in the sera of 17/94 (18%) HNSCCs and 13/76 (17%) lung cancers, including 5/18 (26%) squamous-cell carcinomas. Anti-p40 AIS antibodies were not associated with factors such as sex, age, histopathological grading, extent or size of primary tumor, lymph node involvement and staging. Our results indicate that amplification and over-expression of p40 AIS may lead to antigen recognition by an autologous host with cancer. AIS may thus represent a new group of developmentally regulated genes that are recognized as tumor antigens.


πŸ“œ SIMILAR VOLUMES


Antibodies reactive with the mouse mamma
✍ Steven S. Witkin; Nurul H. Sarkar; David W. Kinne; Robert A. Good; Noorbibi K. D πŸ“‚ Article πŸ“… 1980 πŸ› John Wiley and Sons 🌐 French βš– 483 KB πŸ‘ 1 views

## Abstract IgG binding to purified mouse mammary tumor virus (MuMTV) was quantitated by an enzyme‐linked immunoassay (ELISA) using sera from patients with breast cancer or benign breast disease, or from healthy agematched controls. Significantly greater binding (p<0.01) was found in breast‐cancer‐

Further investigations of circulating an
✍ E. Collatz; S. von Kleist; P. Burtin πŸ“‚ Article πŸ“… 1971 πŸ› John Wiley and Sons 🌐 French βš– 445 KB πŸ‘ 1 views

## Abstract Sera from 190 patients (including 125 patients with cancer of the digestive tract) have been investigated for the presence of circulating antibodies directed against the carcinoembryonic antigen (CEA). Use of three different techniques (passive hemagglutination, immunoadsorption and imm

Switching the fiber knob of oncolytic ad
✍ Mari Raki; Merja Sarkioja; Sophie Escutenaire; Lotta Kangasniemi; Elina Haavisto πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 326 KB

## Abstract ## Background Oncolytic adenoviruses are an attractive strategy for treating cancers resistant to conventional treatments. However, their systemic utility could be limited as a result of the high prevalence of pre‐existing immunity towards the vector. Furthermore, neutralizing antibodi

The significance of isolation of saproph
✍ Michail S. Lionakis; Dimitrios P. Kontoyiannis πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 101 KB πŸ‘ 3 views

## Abstract ## BACKGROUND Invasive infections caused by molds other than __Aspergillus__, __Fusarium__, and __Zygomycetes__ have been reported sporadically in patients with leukemia and allogeneic bone marrow transplantation (BMT). However, the significance of lower respiratory tract cultures that

The lower level of natural anti-thomsen-
✍ Oleg Kurtenkov; Kersti Klaamas; Ljudmila Miljukhina πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 French βš– 498 KB πŸ‘ 1 views

## Abstract The TFA is a tumorassociated, bloodgrouprelated glycosidic precursor structure [Gal(Ξ²^1‐3^)GalNAc]. Its expression in carcinomas is accompanied by a decrease of natural TFA antibodies in serum. The relationship between the ABO(H)‐bloodgroup phenotype and natural anti‐TFA immune response